Literature DB >> 27881841

Novel and recurrent XYLT1 mutations in two Turkish families with Desbuquois dysplasia, type 2.

Long Guo1, Nursel H Elcioglu2, Aritoshi Iida1, Yasemin K Demirkol2, Seda Aras2, Naomichi Matsumoto3, Gen Nishimura4, Noriko Miyake3, Shiro Ikegawa1.   

Abstract

Desbuquois dysplasia (DBQD) is an autosomal recessive skeletal disorder characterized by growth retardation, joint laxity, short extremities, and progressive scoliosis. DBQD is classified into two types based on the presence (DBQD1) or absence (DBQD2) of characteristic hand abnormalities. CANT1 mutations have been reported in both DBQD1 and DBQD2. Recently, mutations in the gene encoding xylosyltransferase 1 (XYLT1) were identified in several families with DBQD2. In this study, we performed whole-exome sequencing in two Turkish families with DBQD2. We found a novel and a recurrent XYLT1 mutation in each family. The patients were homozygous for the mutations. Our results further support that XYLT1 is responsible for a major subset of DBQD2.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27881841     DOI: 10.1038/jhg.2016.143

Source DB:  PubMed          Journal:  J Hum Genet        ISSN: 1434-5161            Impact factor:   3.172


  20 in total

1.  The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data.

Authors:  Aaron McKenna; Matthew Hanna; Eric Banks; Andrey Sivachenko; Kristian Cibulskis; Andrew Kernytsky; Kiran Garimella; David Altshuler; Stacey Gabriel; Mark Daly; Mark A DePristo
Journal:  Genome Res       Date:  2010-07-19       Impact factor: 9.043

2.  Desbuquois dysplasia type II in a patient with a homozygous mutation in XYLT1 and new unusual findings.

Authors:  Cynthia Silveira; Gabriela F Leal; Denise P Cavalcanti
Journal:  Am J Med Genet A       Date:  2016-08-02       Impact factor: 2.802

3.  Atypical giant axonal neuropathy arising from a homozygous mutation by uniparental isodisomy.

Authors:  S Miyatake; H Tada; S Moriya; J Takanashi; Y Hirano; M Hayashi; Y Oya; M Nakashima; Y Tsurusaki; N Miyake; N Matsumoto; H Saitsu
Journal:  Clin Genet       Date:  2014-09-08       Impact factor: 4.438

4.  Chondrodysplasia and abnormal joint development associated with mutations in IMPAD1, encoding the Golgi-resident nucleotide phosphatase, gPAPP.

Authors:  Lisenka E L M Vissers; Ekkehart Lausch; Sheila Unger; Ana Belinda Campos-Xavier; Christian Gilissen; Antonio Rossi; Marisol Del Rosario; Hanka Venselaar; Ute Knoll; Sheela Nampoothiri; Mohandas Nair; Jürgen Spranger; Han G Brunner; Luisa Bonafé; Joris A Veltman; Bernhard Zabel; Andrea Superti-Furga
Journal:  Am J Hum Genet       Date:  2011-05-05       Impact factor: 11.025

5.  XYLT1 mutations in Desbuquois dysplasia type 2.

Authors:  Catherine Bui; Céline Huber; Beyhan Tuysuz; Yasemin Alanay; Christine Bole-Feysot; Jules G Leroy; Geert Mortier; Patrick Nitschke; Arnold Munnich; Valérie Cormier-Daire
Journal:  Am J Hum Genet       Date:  2014-02-27       Impact factor: 11.025

6.  Desbuquois dysplasia, a reevaluation with abnormal and "normal" hands: radiographic manifestations.

Authors:  Laurence Faivre; Valérie Cormier-Daire; Alison M Eliott; Fiona Field; Arnold Munnich; Pierre Maroteaux; Martine Le Merrer; Ralph Lachman
Journal:  Am J Med Genet A       Date:  2004-01-01       Impact factor: 2.802

7.  The diastrophic dysplasia gene encodes a novel sulfate transporter: positional cloning by fine-structure linkage disequilibrium mapping.

Authors:  J Hästbacka; A de la Chapelle; M M Mahtani; G Clines; M P Reeve-Daly; M Daly; B A Hamilton; K Kusumi; B Trivedi; A Weaver
Journal:  Cell       Date:  1994-09-23       Impact factor: 41.582

8.  The missing "link": an autosomal recessive short stature syndrome caused by a hypofunctional XYLT1 mutation.

Authors:  Julia Schreml; Burak Durmaz; Ozgur Cogulu; Katharina Keupp; Filippo Beleggia; Esther Pohl; Esther Milz; Mahmut Coker; Sema Kalkan Ucar; Gudrun Nürnberg; Peter Nürnberg; Joachim Kuhn; Ferda Ozkinay
Journal:  Hum Genet       Date:  2013-08-27       Impact factor: 4.132

9.  Exome sequencing reveals two novel compound heterozygous XYLT1 mutations in a Polish patient with Desbuquois dysplasia type 2 and growth hormone deficiency.

Authors:  Aleksander Jamsheer; Ewelina M Olech; Kazimierz Kozłowski; Marek Niedziela; Anna Sowińska-Seidler; Monika Obara-Moszyńska; Anna Latos-Bieleńska; Marek Karczewski; Tomasz Zemojtel
Journal:  J Hum Genet       Date:  2016-03-31       Impact factor: 3.172

Review 10.  Synthesis and sorting of proteoglycans.

Authors:  K Prydz; K T Dalen
Journal:  J Cell Sci       Date:  2000-01       Impact factor: 5.285

View more
  14 in total

Review 1.  What is new in CDG?

Authors:  Jaak Jaeken; Romain Péanne
Journal:  J Inherit Metab Dis       Date:  2017-05-08       Impact factor: 4.982

2.  GGC Repeat Expansion and Exon 1 Methylation of XYLT1 Is a Common Pathogenic Variant in Baratela-Scott Syndrome.

Authors:  Amy J LaCroix; Deborah Stabley; Rebecca Sahraoui; Margaret P Adam; Michele Mehaffey; Kelly Kernan; Candace T Myers; Carrie Fagerstrom; George Anadiotis; Yassmine M Akkari; Katherine M Robbins; Karen W Gripp; Wagner A R Baratela; Michael B Bober; Angela L Duker; Dan Doherty; Jennifer C Dempsey; Daniel G Miller; Martin Kircher; Michael J Bamshad; Deborah A Nickerson; Heather C Mefford; Katia Sol-Church
Journal:  Am J Hum Genet       Date:  2018-12-13       Impact factor: 11.025

3.  Dysosteosclerosis is also caused by TNFRSF11A mutation.

Authors:  Long Guo; Nursel H Elcioglu; Ozge K Karalar; Mert O Topkar; Zheng Wang; Yuma Sakamoto; Naomichi Matsumoto; Noriko Miyake; Gen Nishimura; Shiro Ikegawa
Journal:  J Hum Genet       Date:  2018-03-22       Impact factor: 3.172

4.  Recapitulating the human segmentation clock with pluripotent stem cells.

Authors:  Mitsuhiro Matsuda; Yoshihiro Yamanaka; Maya Uemura; Mitsujiro Osawa; Megumu K Saito; Ayako Nagahashi; Megumi Nishio; Long Guo; Shiro Ikegawa; Satoko Sakurai; Shunsuke Kihara; Thomas L Maurissen; Michiko Nakamura; Tomoko Matsumoto; Hiroyuki Yoshitomi; Makoto Ikeya; Noriaki Kawakami; Takuya Yamamoto; Knut Woltjen; Miki Ebisuya; Junya Toguchida; Cantas Alev
Journal:  Nature       Date:  2020-04-01       Impact factor: 49.962

5.  Identification of biallelic EXTL3 mutations in a novel type of spondylo-epi-metaphyseal dysplasia.

Authors:  Long Guo; Nursel H Elcioglu; Shuji Mizumoto; Zheng Wang; Bilge Noyan; Hatice M Albayrak; Shuhei Yamada; Naomichi Matsumoto; Noriko Miyake; Gen Nishimura; Shiro Ikegawa
Journal:  J Hum Genet       Date:  2017-03-23       Impact factor: 3.172

6.  CANT1 deficiency in a mouse model of Desbuquois dysplasia impairs glycosaminoglycan synthesis and chondrocyte differentiation in growth plate cartilage.

Authors:  Kazuki Kodama; Hiroaki Takahashi; Nobuyasu Oiji; Kenta Nakano; Tadashi Okamura; Kimie Niimi; Eiki Takahashi; Long Guo; Shiro Ikegawa; Tatsuya Furuichi
Journal:  FEBS Open Bio       Date:  2020-04-23       Impact factor: 2.693

Review 7.  The clinical and mutational spectrum of B3GAT3 linkeropathy: two case reports and literature review.

Authors:  Marlies Colman; Tim Van Damme; Elisabeth Steichen-Gersdorf; Franco Laccone; Sheela Nampoothiri; Delfien Syx; Brecht Guillemyn; Sofie Symoens; Fransiska Malfait
Journal:  Orphanet J Rare Dis       Date:  2019-06-13       Impact factor: 4.123

Review 8.  Further Defining the Phenotypic Spectrum of B3GAT3 Mutations and Literature Review on Linkeropathy Syndromes.

Authors:  Marco Ritelli; Valeria Cinquina; Edoardo Giacopuzzi; Marina Venturini; Nicola Chiarelli; Marina Colombi
Journal:  Genes (Basel)       Date:  2019-08-21       Impact factor: 4.096

Review 9.  Chondrodysplasias With Multiple Dislocations Caused by Defects in Glycosaminoglycan Synthesis.

Authors:  Johanne Dubail; Valérie Cormier-Daire
Journal:  Front Genet       Date:  2021-06-16       Impact factor: 4.599

10.  Novel and recurrent COL11A1 and COL2A1 mutations in the Marshall-Stickler syndrome spectrum.

Authors:  Long Guo; Nursel H Elcioglu; Zheng Wang; Yasemin K Demirkol; Pinar Isguven; Naomichi Matsumoto; Gen Nishimura; Noriko Miyake; Shiro Ikegawa
Journal:  Hum Genome Var       Date:  2017-10-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.